| Literature DB >> 35117855 |
Ming-Xi Zhu1, Yan Li2.
Abstract
BACKGROUND: The incidence and mortality rates of intrahepatic cholangiocarcinoma (ICC) continue to increase in the United States (US). To our knowledge, the associations between socioeconomic factors (SES) and ICC-associated incidence and survival are still unclear.Entities:
Keywords: Intrahepatic cholangiocarcinoma (ICC); SEER, socioeconomic; incidence; survival
Year: 2020 PMID: 35117855 PMCID: PMC8798916 DOI: 10.21037/tcr-20-2506
Source DB: PubMed Journal: Transl Cancer Res ISSN: 2218-676X Impact factor: 1.241
Figure 1Flow diagram for the study.
Incidence rates and rates ratios by sex, age, race, and SES
| Variable | N | Pop | Rate | RR | 95% CI | P |
|---|---|---|---|---|---|---|
| Sex | ||||||
| Male | 2,529 | 172,930,831 | 1.494 | 1 | Reference | |
| Female | 2,455 | 180,430,159 | 1.203 | 0.806 | 0.761–0.853 | <0.001 |
| Age | ||||||
| 18–44 | 205 | 151,600,151 | 0.150 | 1 | Reference | |
| 45–54 | 504 | 61,074,142 | 0.806 | 5.391 | 4.573–6.377 | <0.001 |
| 55–64 | 1,247 | 52,973,324 | 2.341 | 15.662 | 13.500–18.255 | <0.001 |
| 65–74 | 1,412 | 32,552,039 | 4.393 | 29.384 | 25.358–34.212 | <0.001 |
| >75 | 1,615 | 25,101,436 | 6.428 | 43.001 | 37.156–50.007 | <0.001 |
| Race | ||||||
| White | 3,950 | 265,798,955 | 1.329 | 1 | Reference | |
| Black | 392 | 43,383,759 | 1.045 | 0.786 | 0.704–0.876 | <0.001 |
| API | 36 | 5,577,534 | 0.844 | 0.635 | 0.434–0.895 | 0.007 |
| AI | 594 | 38,600,742 | 1.651 | 1.243 | 1.136–1.357 | <0.001 |
| Education level‡ | ||||||
| < Quartile 1 | 1,351 | 71,345,128 | 1.723 | 1 | Reference | |
| < Quartile 2 | 1,401 | 84,916,625 | 1.555 | 0.902 | 0.835–0.974 | 0.009 |
| < Quartile 3 | 1,036 | 76,342,535 | 1.301 | 0.755 | 0.694–0.820 | <0.001 |
| > Quartile 3 | 1,195 | 90,696,804 | 1.303 | 0.756 | 0.698–0.819 | <0.001 |
| Unemployment level‡ | ||||||
| < Quartile 1 | 194 | 11,231,121 | 1.422 | 1 | Reference | |
| < Quartile 2 | 1,074 | 65,451,933 | 1.539 | 1.082 | 0.925–1.271 | 0.345 |
| < Quartile 3 | 2,126 | 140,234,874 | 1.399 | 0.984 | 0.846–1.148 | 0.851 |
| > Quartile 3 | 1,596 | 136,641,258 | 1.145 | 0.805 | 0.691–0.942 | 0.007 |
| Median housed income‡ | ||||||
| < Quartile 1 | 240 | 24,901,604 | 0.803 | 1 | Reference | |
| < Quartile 2 | 452 | 39,653,072 | 1.007 | 1.254 | 1.066–1.478 | 0.006 |
| < Quartile 3 | 552 | 54,133,604 | 0.945 | 1.176 | 1.005–1.379 | 0.043 |
| > Quartile 3 | 3,741 | 321,806,008 | 1.090 | 1.357 | 1.187–1.557 | <0.001 |
| Resident‡ | ||||||
| Metro area | 4,446 | 394,77,102 | 1.066 | 1 | Reference | |
| Non-metro urban area | 465 | 40,321,396 | 0.891 | 0.836 | 0.756–0.922 | 0.003 |
| Non-metro rural area | 73 | 4,813,276 | 1.059 | 0.993 | 0.993–0.772 | 1.000 |
‡, all data are county-level; education level is the percentage of patients aged ≥25 years with at least a high school diploma. CI, confidence interval; RR, rates ratios; SES, socioeconomic status.
Univariate and multivariate Cox analysis of the effect of SES on CSS and OS in ICC
| Variable | Patient No. (%) | CSS | OS | ||||
|---|---|---|---|---|---|---|---|
| Univariate analysis, HR (95% CI) | Multivariate analysis, HR (95% CI) | Univariate analysis, HR (95% CI) | Multivariate analysis, HR (95% CI) | ||||
| Gender | |||||||
| Male | 1,763 (51.0) | Reference | Reference | Reference | Reference | ||
| Female | 1,693 (49.0) | 0.837 (0.771–0.910)** | 0.807 (0.723–0.902)** | 0.901 (0.833–0.975)* | 0.807 (0.726–0.897)** | ||
| Age at diagnosis, year | |||||||
| <45 | 168 (4.9) | Reference | Reference | Reference | Reference | ||
| 45–65 | 1,461 (42.3) | 1.349 (1.100–1.654)* | 1.397 (1.072–1.819)* | 1.330 (1.091–1.622)* | 1.401 (1.080–1.817)* | ||
| 65+ | 1,827 (52.9) | 1.801 (1.472–2.205)** | 1.845 (1.417–2.403)** | 1.827 (1.501–2.222)** | 1.919 (1.480–2.487)** | ||
| Race | |||||||
| White | 2,698 (78.1) | Reference | Reference | Reference | Reference | ||
| Black | 285 (8.2) | 1.107 (0.957–1.280) | 1.050 (0.868–1.270) | 1.116 (0.970–1.285) | 1.113 (0.928–1.336) | ||
| Other | 468 (13.5) | 0.953 (0.845–1.074) | 0.977 (0.828–1.152) | 0.968 (0.863–1.087) | 0.976 (0.833–1.146) | ||
| Marital status | |||||||
| Married | 2,041 (59.1) | Reference | Reference | Reference | Reference | ||
| Unmarried | 1,415 (40.9) | 1.230 (1.134–1.335)** | 1.229 (1.097–1.377)** | 1.225 (1.132–1.326)** | 1.205 (1.079–1.345)* | ||
| Insurance status | |||||||
| Uninsured | 611 (17.7) | Reference | Reference | Reference | Reference | ||
| Insured | 2,845 (82.3) | 0.810 (0.728–0.900)** | 0.846 (0.731–0.979)* | 0.785 (0.710–0.869)** | 0.813 (0.706–0.936)* | ||
| Education level‡ | |||||||
| < Quartile 1 (9.53%) | 2,645 (76.5) | Reference | Reference | Reference | Reference | ||
| < Quartile 2 (13.06%) | 307 (8.9) | 1.190 (1.034–1.369)* | 1.119 (0.924–1.355) | 1.191 (1.039–1.365)* | 1.135 (0.942–1.369) | ||
| < Quartile 3 (18.74%) | 450 (13.0) | 1.193 (1.057–1.347)* | 1.200 (0.981–1.467) | 1.229 (1.094–1.381)* | 1.022 (0.955–1.210) | ||
| ≥ Quartile 3 (18.74%) | 54 (1.6) | 1.324 (0.985–1.780) | 1.136 (0.779–1.656) | 1.333 (1.001–1.776)* | 1.178 (0.817–1.697) | ||
| Unemployment rate‡ | |||||||
| < Quartile 1 | 125 (3.6) | Reference | Reference | ||||
| < Quartile 2 | 743 (21.5) | 1.128 (0.892–1.426) | – | 1.129 (0.898–1.420) | – | ||
| < Quartile 3 | 1484 (42.9) | 1.129 (0.900–1.416) | – | 1.146 (0.9149–1.429) | – | ||
| ≥ Quartile 3 | 1104 (31.9) | 1.219 (0.969–1.533) | – | 1.241 (0.993–1.552) | – | ||
| Median household income‡ | |||||||
| <Quartile 1 (US $5,289) | 865 (25.0) | Reference | Reference | Reference | Reference | ||
| <Quartile 2 (US $5,995) | 892 (25.8) | 0.887 (0.793–0.992)* | 0.793 (0.672–0.936)* | 0.903 (0.810–0.989)* | 0.806 (0.709–0.915)* | ||
| <Quartile 3 (US $7,446) | 852 (24.7) | 0.835 (0.746–0.934)* | 0.853 (0.725–0.946)* | 0.840 (0.753–0.937)* | 0.813 (0.713–0.927)* | ||
| ≥Quartile 3 (US $7,446) | 847 (24.5) | 0.774 (0.690–0.868)** | 0.749 (0.630–0.891)* | 0.804 (0.720–0.869)** | 0.801 (0.696–0.921)* | ||
| Residence‡ | |||||||
| Metro area | 3,099 (89.7) | Reference | Reference | Reference | Reference | ||
| Non–metro urban area | 241 (7.0) | 1.164 (0.999–1.355) | 1.167 (0.946–1.440) | 1.135 (0.978–1.318) | 1.160 (0.943–1.427) | ||
| Non–metro rural area | 93 (2.7) | 1.350 (1.067–1.708)* | 1.229 (0.892–1.692) | 1.337 (1.063–1.680)* | 1.213 (0.884–1.664) | ||
| T category | |||||||
| T1 | 891 (25.8) | Reference | Reference | Reference | Reference | ||
| T2 | 400 (11.6) | 1.057 (0.929–1.202) | 1.042 (0.881–1.2338) | 1.030 (0.910–1.167)** | 1.273 (1.122–1.444)** | ||
| T3 | 772 (22.3) | 1.381 (1.225–1.558)** | 1.228 (1.077–.1402)* | 1.339 (1.192–1.505)** | 1.303 (1.179–1.440)** | ||
| T4 | 406 (11.7) | 1.438 (1.247–1.658)** | 1.255 (1.074–1.467)* | 1.397 (1.216–1.604)** | 1.257 (1.110–1.422)** | ||
| N category | |||||||
| N0 | 2,089 (60.4) | Reference | Reference | Reference | Reference | ||
| N1 | 820 (23.7) | 1.165 (1.056–1.285)* | 1.034 (0.917–1.167) | 1.141 (1.037–1.256)* | 1.035 (0.920–1.164) | ||
| M category | |||||||
| M0 | 1,672 (48.4) | Reference | Reference | Reference | Reference | ||
| M1 | 1,461 (42.3) | 1.903 (1.744–2.076)** | 1.478 (1.320–1.656)** | 1.841 (1.692–2.003)** | 1.437 (1.287–1.605)** | ||
| First–course surgery | |||||||
| No | 2,872 (83.1) | Reference | Reference | Reference | Reference | ||
| Yes | 577 (16.7) | 0.215 (0.186–0.250)** | 0.284 (0.240–0.337)** | 0.220 (0.190–0.254)** | 0.228 (0.244–0.339)** | ||
‡, all data are county-level; education level is the percentage of patients aged ≥25 years with at least a high school diploma. *, P<0.050; **, P value ≤0.001. CI, confidence interval. Other races (American Indian/AK Native, Asian/Pacific Islander). CSS, cause-specific survival; ICC, intrahepatic cholangiocarcinoma; OS, overall survival; TNM, tumor-node metastasis; SES, socioeconomic status
Figure 2Kaplan-Meier survival curves for overall survival (A) and cause-specific survival (B) based on the prognostic score model in patients with intrahepatic cholangiocarcinoma. (A) log-rank χ2 test =64.44, P<0.001; (B) log-rank χ2 test =60.12, P<0.001.
Figure 3Kaplan-Meier survival curves for overall survival in men (A) and women (C), as well as for cause-specific survival in men (B) and women (D) based on the prognostic score model in patients with intrahepatic cholangiocarcinoma. (A) log-rank χ2 test =58.09, P<0.001; (B) log-rank χ2 test =53.12, P<0.001; (C) log-rank χ2 test =25.23, P<0.001; (D) log-rank χ2 test =22.19, P<0.001.
Figure 4Kaplan-Meier survival curves for overall survival and cause-specific survival in age at diagnosis <45 (A,B), 45–65 (C,D), 65+ (E,F) based on the prognostic score model in patients with intrahepatic cholangiocarcinoma. (A) log-rank χ2 test =17.86, P<0.001; (B) log-rank χ2 test =15.82, P<0.05; (C) log-rank χ2 test =62.91, P<0.001; (D) log-rank χ2 test =17.82, P<0.001; (E) log-rank χ2 test =20.18, P<0.001; (F) log-rank χ2 test =17.82, P<0.001.